Antimicrobial Resistance – 2017 BIO Investor Forum to Address Current Status

Alarm bells have been sounding for some time that deadly infections are developing resistance to the drugs available to treat them. For decades, new drugs were deployed when existing drugs proved insufficient, keeping the problem at bay. But economic realities may block further advances, creating a public health threat.
A panel session at this year’s BIO Investor Forum will address these concerns and the funding opportunities for developing new agents to treat all types of infections.
BIOt